Diabetic Neuropathies: Features and Mechanisms
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Diabetic neuropathies include both focal neuropathies and diffuse poly neuropathy. Polyneuropathy, the most common of the diabetic neuropathies excluding focal entrapment, has not yet been explained by a single disease mechanism despite intensive investigation. A number of abnormalities appear to cascade into a ‘vicious cycle’ of progressive microvascular disease associated with motor, sensory and autonomie fiber loss. These abnormalities include excessive polyol (sugar alcohol) flux through the aldose reductase pathway, functional and structural alterations of nerve microvessels, nerve and ganglia hypoxia, oxidative stress, nonspecific glycosylation of axon and microvessel proteins, and impairment in the elaboration of trophic factors critical for peripheral nerves and their ganglia. While an initiating role for nerve ischemia in the development of poly neuropathy has been proposed, the evidence for it can be questioned. The role of sensory and autonomie ganglia in the development of poly neuropathy has had relatively less attention despite the possibility that they may be vulnerable to a variety of insults, particularly neurotrophin deficiency. Superimposed on the deficits of polyneuropathy is the failure of diabetic nerves to regenerate as effectively as nondiabetics. Polyneuropathy has not yet yielded to specific forms of treatment but a variety of new trials addressing plausible hypotheses have been initiated. This review will summarize some of the clinical, pathological and experimental work applied toward understanding human diabetic neuropathy and will emphasize ideas on pathogenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Disorders of gastrointestinal motility associated with diabetes mellitus
FELDMAN, M., & SCHILLER, L. R. (1983) · Annals of Internal Medicine · doi:10.7326/0003-4819-98-3-378 · Cited by 653 · cited 1×
“In the lower gut diarrhea, often nocturnal, and constipation are problems and fecal incontinence may occur (7, 62, 161).”
BackgroundZiegler, D., Hanefeld, M., Ruhnau, K. J., Mei\ner, H. P., Lobisch, M., Sch�tte, K., Gries, F. A., & The ALADIN Study Group (1995) · Diabetologia · doi:10.1007/bf00400603 · Cited by 525
Dahl-Jørgensen, K., Brinchmann-Hansen, O., Hanssen, K. F., Sandvik, L., & Aagenaes, O. (1985) · BMJ · doi:10.1136/bmj.290.6471.811 · Cited by 360
Autonomic Neural Dysfunction in Recently Diagnosed Diabetic Subjects
Pfeifer, M. A., Weinberg, C. R., Cook, D. L., Reenan, A., Halter, J. B., Ensinck, J. W., & Porte, D. (1984) · Diabetes Care · doi:10.2337/diacare.7.5.447 · Cited by 266
Diabetic autonomic neuropathy: present insights and future prospects
Ewing, D. J., & Clarke, B. F. (1986) · Diabetes Care · doi:10.2337/diacare.9.6.648 · Cited by 155
Cited by
Vinik, A. I., Park, T. S., Stansberry, K. B., & Pittenger, G. L. (2000) · Diabetologia · doi:10.1007/s001250051477 · Cited by 489
Polyol pathway and diabetic peripheral neuropathy
Oates, P. J. (2002) · International Review of Neurobiology · doi:10.1016/s0074-7742(02)50082-9 · Cited by 322
Epalrestat: An Aldose Reductase Inhibitor for the Treatment of Diabetic Neuropathy
Ramirez, M. A., & Borja, N. L. (2008) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.28.5.646 · Cited by 303
Short‐term hyperglycemia produces oxidative damage and apoptosis in neurons
Vincent, A. M., Mclean, L. L., Backus, C., & Feldman, E. L. (2005) · The FASEB Journal · doi:10.1096/fj.04-2513fje · Cited by 295
A role for mitogen‐activated protein kinases in the etiology of diabetic neuropathy
PURVES, T., MIDDLEMAS, A., AGTHONG, S., JUDE, E. B., BOULTON, A. J. M., FERNYHOUGH, P., & TOMLINSON, D. R. (2001) · The FASEB Journal · doi:10.1096/fj.01-0253hyp · Cited by 274
Metadata
- Authors
- Zochodne, D. W.
- Venue
- Brain Pathology
- Publisher
- Wiley
- Published
- 1999-04
- Volume
- 9
- Issue
- 2
- Pages
- 369-391
- ISSN
- 1015-6305 (ISSN-L)
- 1750-3639
- OpenAlex
- W1986184217
- Cited by
- 95
- References
- 5
- FWCI
- 2.45
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Diabetic Neuropathies: Features and Mechanisms. https://app.cochat.ai/papers/10.1111/j.1750-3639.1999.tb00233.x
- The paper
- Zochodne, D. W. (1999). Diabetic Neuropathies: Features and Mechanisms. Brain Pathology. https://doi.org/10.1111/j.1750-3639.1999.tb00233.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.